德意志银行在诺和诺德股价较峰值下跌70%后，将这家Ozempic生产商的评级下调至卖出。此次下调评级打破了华尔街分析师此前不愿建议投资者卖出诺和诺德股票的惯例。引述“华尔街分析师仍不愿建议投资者卖出该股”— MarketWatch来源Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peakMarketWatch